EFDID: 159719EFD: View Filing

Issuer: Romark Global Pharma, LLC (0001666694) - D/A

Accession: 0000897069-17-000156 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001666694
  • Entity Name:
    Romark Global Pharma, LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    PUERTO RICO
  • Year of Inc:
    Within 5 years (2014)
  • Address:
    B5 TABONUCO STREET, SUITE #216, PMT 317
    GUAYNABO, PR 00968
  • Persons:
    Related Persons 6
    Jean-Francois Rossignol, M.D., Ph.D.
    Executive Officer, Director, Promoter
    Marc S. Ayers
    Executive Officer, Director, Promoter
    Celine Rossignol
    Executive Officer
    Wayne Burks
    Executive Officer
    W. Seymour Holt
    Director
    W. Andrew Krusen Jr.
    Director
EDGAR: Offering Information
  • Accession Date:
    03/08/2017
  • First Sale Date:
    10/09/2015
  • Offering Amount:
    $50,000,000
  • Amount Sold:
    $13,835,000
  • Amount Remaining:
    $36,165,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt, Convertible into Romark SCS Common Units
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:None
Inactive:PR
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Francisco Jose Rivera 2303039 Pariter Securities, LLC 127836 PR
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Romark Global Pharma, LLCWayne BurksWayne BurksChief Financial Officer2017-03-08
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Mar. 08, 2017 159719: 0000897069-17-000156 Romark Global Pharma, LLC
Offer Amount: $50,000,000
Amount Sold: $13,835,000
Remaining: $36,165,000
D/A Mar. 15, 2016 159719: 0000897069-16-000764 Romark Global Pharma, LLC
Offer Amount: $50,000,000
Amount Sold: $10,710,000
Remaining: $39,290,000
D Feb. 24, 2016 159719: 0000897069-16-000727 Romark Global Pharma, LLC
Offer Amount: $50,000,000
Amount Sold: $10,710,000
Remaining: $39,290,000